Shi Ma
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Aging top 10%
Papers in ⓘ
-
- Cancer-related gene regulation 6
- Wnt/β-catenin signaling in development and cancer 5
- Retinal Development and Disorders 4
-
- Retinal Diseases and Treatments 4
- Glaucoma and retinal disorders 3
- Co-authors
- Zhenglin Yang (18 shared papers)Fang Lü (12 shared papers)Lulin Huang (11 shared papers)Peiquan Zhao (7 shared papers)Bo Gong (9 shared papers)Lin He (8 shared papers)Xiaoqi Liu (7 shared papers)Xiong Zhu (7 shared papers)
- Journals
- PLoS ONE (3 papers)Scientific Reports (2 papers)Journal of the Neurological Sciences (1 paper)Human Molecular Genetics (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- ChinaIndiaUnited States
In The Last Decade
Shi Ma
30 papers receiving 423 citations
Peers
Comparison fields: 5 of 72
- Ophthalmology 129
- Aging 21
- Neurology 54
- Radiology, Nuclear Medicine and Imaging 108
- Molecular Biology 235
Countries citing papers authored by Shi Ma
This map shows the geographic impact of Shi Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Ma more than expected).
Fields of papers citing papers by Shi Ma
This network shows the impact of papers produced by Shi Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Ma. The network helps show where Shi Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Shi Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 56 | |
| 2 | 2021 | 48 | |
| 3 | 2017 | 38 | |
| 4 | 2014 | 31 | |
| 5 | Identification of two novel LRP5 mutations in families with familial exudative vitreoretinopathy. | 2014 | 24 |
| 6 | 2013 | 23 | |
| 7 | Evaluation of MMP2 as a candidate gene for high myopia. | 2013 | 19 |
| 8 | Novel mutations in the TSPAN12 gene in Chinese patients with familial exudative vitreoretinopathy. | 2014 | 19 |
| 9 | 2018 | 19 | |
| 10 | An association study of the COL1A1 gene and high myopia in a Han Chinese population. | 2011 | 18 |
| 11 | 2012 | 16 | |
| 12 | 2015 | 16 | |
| 13 | 2014 | 15 | |
| 14 | 2010 | 14 | |
| 15 | 2015 | 13 | |
| 16 | 2015 | 12 | |
| 17 | 2013 | 10 | |
| 18 | 2017 | 8 | |
| 19 | 2020 | 7 | |
| 20 | 2020 | 6 |
About Shi Ma
Shi Ma is a scholar working on Molecular Biology, Ophthalmology, Radiology, Nuclear Medicine and Imaging, Cellular and Molecular Neuroscience and Epidemiology, having authored 31 papers that have together received 429 indexed citations. Recurring topics across this work include Cancer-related gene regulation (6 papers), Wnt/β-catenin signaling in development and cancer (5 papers), Retinal Diseases and Treatments (4 papers), Retinal Development and Disorders (4 papers), Glaucoma and retinal disorders (3 papers), Ophthalmology and Visual Impairment Studies (3 papers), Genetics, Aging, and Longevity in Model Organisms (2 papers) and Renal Diseases and Glomerulopathies (2 papers). The work is most often cited by research in Ophthalmology (129 citations), Aging (21 citations), Neurology (54 citations), Radiology, Nuclear Medicine and Imaging (108 citations) and Molecular Biology (235 citations). Shi Ma has collaborated with scholars based in China, India and United States. Frequent co-authors include Zhenglin Yang, Fang Lü, Lulin Huang, Peiquan Zhao, Bo Gong, Lin He, Xiaoqi Liu, Xiong Zhu, Xianjun Zhu and Dingding Zhang. Their work appears in journals such as PLoS ONE, Scientific Reports, Journal of the Neurological Sciences, Human Molecular Genetics and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.